Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Improved Survival of Children, Adolescents, and Young Adults With Head and Neck Soft Tissue Sarcomas in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Liposomal Cytarabine Induces Less Neurocognitive Dysfunction Than Intrathecal Methotrexate in an Animal Model

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Hepatotoxicity During Maintenance Therapy and Prognosis in Children With Acute Lymphoblastic Leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Successful Treatment of Rhino-Orbital-Cerebral Mucormycosis in a Child With Leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Early Postoperative 18F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. 18F-FET PET/MRI for CNS-tumors in children and adolescents

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  3. Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Anne-Sofie Skou
  • Steen Ø Olsen
  • Lars H Nielsen
  • Heidi Glosli
  • Kirsi Jahnukainen
  • Marianne Jarfelt
  • Guðmundur K Jónmundsson
  • Johan Malmros
  • Karsten Nysom
  • Henrik Hasle
  • Nordic Society of Pediatric Hematology and Oncology (NOPHO)
View graph of relations

BACKGROUND: As more children survive acute myeloid leukemia (AML) it is increasingly important to assess possible late effects of the intensive treatment. Hearing loss has only sporadically been reported in survivors of childhood AML. We assessed hearing status in survivors of childhood AML treated with chemotherapy alone according to 3 consecutive NOPHO-AML trials.

PROCEDURE: A population-based cohort of children treated according to the NOPHO-AML-84, NOPHO-AML-88, and NOPHO-AML-93 trials included 137 eligible survivors among whom 101 (74%) completed a questionnaire and 99 (72%) had otologic and audiologic examination performed including otoscopy (72%), pure tone audiometry (70%), and tympanometry (60%). Eighty-four of 93 (90%) eligible sibling controls completed a similar questionnaire.

RESULTS: At a median of 11 years (range, 4 to 25) after diagnosis, hearing disorders were rare in survivors of childhood AML and in sibling controls, with no significant differences. None had severe or profound hearing loss diagnosed at audiometry. Audiometry detected a subclinical hearing loss ranging from slight to moderate in 19% of the survivors, 5% had low-frequency hearing loss, and 17% had high-frequency hearing loss.

CONCLUSIONS: The frequency of hearing disorders was low, and hearing thresholds in survivors of childhood AML were similar to background populations of comparable age.

Original languageEnglish
JournalJournal of Pediatric Hematology/Oncology
Volume41
Issue number1
Pages (from-to)e12-e17
ISSN1077-4114
DOIs
Publication statusPublished - Jan 2019

    Research areas

  • acute myeloid leukemia, audiometry, children, hearing loss, late effects

ID: 56614070